Published in Am J Surg Pathol on August 01, 2003
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
IgG4-related sclerosing disease. World J Gastroenterol (2008) 3.84
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol (2006) 3.40
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch (2004) 3.04
Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol (2007) 2.60
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol (2008) 2.31
Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med (2006) 2.08
Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95
Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology (2010) 1.86
Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol (2007) 1.57
Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol (2012) 1.56
Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut (2005) 1.44
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut (2007) 1.43
Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol (2009) 1.42
Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch (2004) 1.35
IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J (2012) 1.26
Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol (2008) 1.18
Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J Immunol (2008) 1.14
Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol (2010) 1.14
Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch (2009) 1.12
Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol (2012) 1.12
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol (2007) 1.10
Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol (2010) 1.08
Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol (2009) 1.06
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J (2011) 1.04
Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J Gastroenterol (2013) 1.04
Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis. J Gastroenterol (2014) 1.02
Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol (2010) 1.01
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol (2010) 1.01
Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol (2004) 0.97
The Utility of Serum IgG4 Concentrations as a Biomarker. Int J Rheumatol (2012) 0.96
Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol (2007) 0.96
Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol (2014) 0.95
Recent advances in autoimmune pancreatitis. Front Physiol (2012) 0.92
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol (2014) 0.92
Diagnostic criteria for autoimmune pancreatitis in Japan. World J Gastroenterol (2008) 0.91
Autoimmune pancreatitis--a new evolving pancreatic disease? Langenbecks Arch Surg (2010) 0.88
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterol J (2013) 0.87
Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. Gastroenterol Hepatol (N Y) (2015) 0.87
Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea. Gut Liver (2013) 0.86
Autoimmune Pancreatitis in Children: Characteristic Features, Diagnosis, and Management. Am J Gastroenterol (2017) 0.86
Regulatory T cells in type 1 autoimmune pancreatitis. Int J Rheumatol (2012) 0.85
Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis (2014) 0.84
Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis. World J Gastroenterol (2013) 0.83
Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis. J Gastroenterol (2012) 0.83
Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol (2013) 0.82
Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol (2007) 0.82
Autoimmune pancreatitis: with special reference to a localized variant. J Med Ultrason (2001) (2008) 0.81
Diagnosis of autoimmune pancreatitis. World J Gastroenterol (2014) 0.81
IgG₄-related sclerosing disease: a novel mimic of inflammatory bowel disease. Dig Dis Sci (2010) 0.81
Chronic pancreatitis: classification, relationship to acute pancreatitis, and early diagnosis. J Gastroenterol (2007) 0.80
Endoscopic ultrasound-guided fine needle aspiration in the differentiation of type 1 and type 2 autoimmune pancreatitis. World J Gastroenterol (2012) 0.80
Acute recurrent pancreatitis: an autoimmune disease? World J Gastroenterol (2008) 0.78
The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration. J Gastroenterol (2012) 0.78
T cell lymphoplasmacellular and eosinophilic infiltration of the pancreas with involvement of the gallbladder and duodenum in non-alcoholic duct-destructive chronic pancreatitis. Langenbecks Arch Surg (2004) 0.78
Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. Int J Rheumatol (2013) 0.78
Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis. J Gastroenterol (2014) 0.77
The therapeutic strategy for autoimmune pancreatitis is subject to the endoscopic features of the duodenal papilla. Therap Adv Gastroenterol (2010) 0.77
Autoimmune pancreatitis: functional and morphological recovery after steroid therapy. World J Gastroenterol (2006) 0.77
Pancreas: Histological diagnostic criteria for autoimmune pancreatitis. Nat Rev Gastroenterol Hepatol (2011) 0.76
Differences between diffuse and focal autoimmune pancreatitis. World J Gastroenterol (2012) 0.76
Autoimmune pancreatitis-related diabetes: quantitative analysis of endocrine islet cells and inflammatory infiltrate. Virchows Arch (2010) 0.76
IgG4-unrelated type 1 autoimmune pancreatitis. World J Gastroenterol (2015) 0.75
IgG4-related thyroiditis: a case report and review of literature. Endocrinol Diabetes Metab Case Rep (2014) 0.75
Ulcerative colitis and immunoglobulin G4. Gut Liver (2013) 0.75
Recent advances in autoimmune pancreatitis. Gastroenterol Hepatol (N Y) (2008) 0.75
Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol (2016) 0.75
A mass in the junction of the body and tail of the pancreas with negative IgG4 serology: IgG4-related disease with negative serology. Am J Case Rep (2015) 0.75
Pancreatic Fungal Ball Presenting as Pseudomass. ACG Case Rep J (2017) 0.75
Autoimmune pancreatitis. Gland Surg (2016) 0.75
Lymphoplasmacytic sclerosing pancreatitis and retroperitoneal fibrosis. HPB Surg (2008) 0.75
Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75
Autoimmune pancreatitis: pathogenesis, latest developments and clinical guidance. Ther Adv Chronic Dis (2014) 0.75
Autoimmune pancreatitis: a case report. Middle East J Dig Dis (2014) 0.75
Transpapillary biliary stenting is a risk factor for pancreatic stones in patients with autoimmune pancreatitis. Endosc Int Open (2016) 0.75
Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis. World J Gastroenterol (2014) 0.75
Deciphering autoimmune pancreatitis, a great mimicker: case report and review of the literature. Case Rep Gastrointest Med (2015) 0.75
Association of newly diagnosed type 1 diabetes and autoimmune pancreatitis. Endocrinol Diabetes Metab Case Rep (2016) 0.75
Autoimmune Pancreatitis. Dig Dis Sci (2017) 0.75
Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis. Virchows Arch (2015) 0.75
Long-term surgical outcomes of patients with type 1 autoimmune pancreatitis. World J Surg (2013) 0.75
Histological evaluation of obliterative phlebitis for the diagnosis of autoimmune pancreatitis. J Gastroenterol (2013) 0.75
Diagnosis and Management of Autoimmune Pancreatitis. Curr Treat Options Gastroenterol (2017) 0.75
[Spectrum of chronic pancreatitis. On the way to etiological classification]. Pathologe (2005) 0.75
[Histopathology of IgG4-related disease]. Z Rheumatol (2016) 0.75
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology (2006) 8.83
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology (2012) 7.22
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology (2003) 4.84
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol (2009) 3.88
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res (2003) 3.39
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24
MR elastography of the liver: preliminary results. Radiology (2006) 3.20
Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol (2007) 3.14
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology (2002) 2.88
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol (2007) 2.82
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg (2008) 2.66
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl (2015) 2.63
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol (2006) 2.48
Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 2.46
Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum (2002) 2.45
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis (2002) 2.41
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology (2007) 2.39
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology (2004) 2.35
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. Clin Cancer Res (2008) 2.32
Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology (2011) 2.30
Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28
Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med (2008) 2.18
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene (2002) 2.16
Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med (2011) 2.14
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery (2005) 2.10
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 2.09
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.09
A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol (2009) 2.06
Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol (2009) 2.04
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg (2008) 2.04
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell (2005) 2.01
The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut (2006) 1.97
Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas (2003) 1.96
Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol (2005) 1.90
Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology (2008) 1.87
Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol (2007) 1.83
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology (2002) 1.80
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer (2005) 1.75
Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology (2002) 1.72
miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One (2011) 1.72
Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology (2012) 1.71
The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol (2002) 1.70
Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68
Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med (2009) 1.67
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut (2012) 1.67
Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest. Pancreatology (2013) 1.67
Cephalexin-induced cholestatic hepatitis. J Clin Gastroenterol (2004) 1.66
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63
Endoscopic therapy is effective for patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2012) 1.63
Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer (2003) 1.62
Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Clin Cancer Res (2006) 1.61
IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol (2006) 1.59
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol (2004) 1.59
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res (2004) 1.55
Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol (2009) 1.55
Microscopic colitis: a review. Am J Gastroenterol (2002) 1.53
Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol (2003) 1.50
Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers (2004) 1.50
Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl (2004) 1.47
Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer (2005) 1.47
Case-based learning in endocrine physiology: an approach toward self-directed learning and the development of soft skills in medical students. Adv Physiol Educ (2013) 1.45
Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology (2007) 1.45
Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol (2003) 1.44
Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci (2011) 1.43
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy. J Clin Oncol (2013) 1.41
Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol (2010) 1.41
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. Am J Clin Pathol (2008) 1.41
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol (2004) 1.41
Recurrent rectal cancer causing lumbosacral plexopathy with perineural spread to the spinal nerves and the sciatic nerve: an anatomic explanation. Clin Anat (2014) 1.40
Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol (2012) 1.40
Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol (2014) 1.39
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol (2004) 1.36